# A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain

> **NCT03081806** · PHASE3 · COMPLETED · sponsor: **Techfields Pharma Co. Ltd** · enrollment: 399 (actual)

## Conditions studied

- Pain Associated With Osteoarthritis of the Knee

## Interventions

- **DRUG:** X0002

## Key facts

- **NCT ID:** NCT03081806
- **Lead sponsor:** Techfields Pharma Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-24
- **Primary completion:** 2024-01-10
- **Final completion:** 2024-01-10
- **Target enrollment:** 399 (ACTUAL)
- **Last updated:** 2024-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081806, "A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis Knee Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03081806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*